Evidence map›Paper›PMID 31124786›Full record

ArticleeLife2019

Comprehensive substrate specificity profiling of the human Nek kinome reveals unexpected signaling outputs.

Bert van de Kooij, Pau Creixell, Anne van Vlimmeren, Brian A Joughin, Chad J Miller, Nasir Haider, Craig D Simpson, Rune Linding, Vuk Stambolic, Benjamin E Turk and 1 more

Abstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. β-catenin turnover is regulated by Nek10-mediated tyrosine phosphorylation in A549 lung adenocarcinoma cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bert van de KooijDepartment of Biology, Massachusetts Institute of Technology, Cambridge, United States.ORCID 0000-0003-1042-8409
Pau CreixellDepartment of Biology, Massachusetts Institute of Technology, Cambridge, United States.
Anne van VlimmerenDepartment of Biology, Massachusetts Institute of Technology, Cambridge, United States.
Brian A JoughinDepartment of Biology, Massachusetts Institute of Technology, Cambridge, United States.ORCID 0000-0003-1022-9450
Chad J MillerDepartment of Pharmacology, Yale School of Medicine, New Haven, United States.
Nasir HaiderDepartment of Medical Biophysics, University of Toronto, Toronto, Canada.
Craig D SimpsonBiotech Research and Innovation Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Rune LindingBiotech Research and Innovation Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Vuk StambolicDepartment of Medical Biophysics, University of Toronto, Toronto, Canada.ORCID 0000-0001-8853-3239
Benjamin E TurkDepartment of Pharmacology, Yale School of Medicine, New Haven, United States.
Michael B YaffeDepartment of Biology, Massachusetts Institute of Technology, Cambridge, United States.ORCID 0000-0002-9547-3251

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Jacqueline A. Lees · 1985 to 2026
$93.9M
TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI NILES, JACQUIN C · 1985 to 2020
$25.6M
Translational CoreP01DK057751 · NIDDK · YALE UNIVERSITY · PI YANG, XIAOYONG · 2001 to 2020
$25.6M
INSTITUTIONAL NATIONAL RESEARCH SERVICE AWARDT32GM007324 · NIGMS · YALE UNIVERSITY · PI BENNETT, ANTON M · 1987 to 2022
$6.2M
Protein Kinase Signaling and Cell Cycle ControlR01ES015339 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAFFE, MICHAEL B · 2007 to 2017
$4.3M
Protein Kinase Signaling in the Genotoxic Stress ResponseR35ES028374 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAFFE, MICHAEL B · 2017 to 2024
$3.9M
Modeling human phosphorylation networks through kinome-wide profilingR01GM104047 · NIGMS · YALE UNIVERSITY · PI TURK, BENJAMIN E, YAFFE, MICHAEL B · 2013 to 2017
$2.4M
Investigating functional sites in protein kinases as targets for cancer mutations and novel drugsK99CA226396 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CREIXELL, PAU · 2018 to 2019
$266k
Dutch Cancer Society BUIT 2015-7546European Union Seventh Framework Programme FP/2007-2013 ERC grant (KINOMEDRIFT)NCI NIH HHS K99 CA226396NCI NIH HHS K99CA226396NCI NIH HHS P30 CA014051NCI NIH HHS P30-CA14051NIDDK NIH HHS P01 DK057751NIEHS NIH HHS P30 ES002109NIEHS NIH HHS P30-ES002109NIEHS NIH HHS R01 ES015339NIEHS NIH HHS R35 ES028374NIGMS NIH HHS R01 GM104047NIGMS NIH HHS T32 GM007324NIH HHS R01-ES015339NIH HHS R01-GM104047NIH HHS R35-ES028374
6 · The paper itself

Abstract

Human NimA-related kinases (Neks) have multiple mitotic and non-mitotic functions, but few substrates are known. We systematically determined the phosphorylation-site motifs for the entire Nek kinase family, except for Nek11. While all Nek kinases strongly select for hydrophobic residues in the -3 position, the family separates into four distinct groups based on specificity for a serine versus threonine phospho-acceptor, and preference for basic or acidic residues in other positions. Unlike Nek1-Nek9, Nek10 is a dual-specificity kinase that efficiently phosphorylates itself and peptide substrates on serine and tyrosine, and its activity is enhanced by tyrosine auto-phosphorylation. Nek10 dual-specificity depends on residues in the HRD+2 and APE-4 positions that are uncommon in either serine/threonine or tyrosine kinases. Finally, we show that the phosphorylation-site motifs for the mitotic kinases Nek6, Nek7 and Nek9 are essentially identical to that of their upstream activator Plk1, suggesting that Nek6/7/9 function as phospho-motif amplifiers of Plk1 signaling.

Indexed as

Signal TransductionSubstrate SpecificityHumansNIMA-Related KinasesPhosphorylationSerineThreonineNIMA-Related KinasesSerineThreoninebiochemistrycancer biologychemical biologykinase biologymitosisNek kinase familyNima-related kinasenonesignalingsubstrate specificity

Identifiers

PMID31124786
PMCPMC6570481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.